Denali Therapeutics Inc.
Ticker: 1714899
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2023 | Q3 FY2023 | Q2 FY2023 | Q2 FY2023 | Q1 FY2023 | Q1 FY2023 | Q3 FY2022 | Q2 FY2022 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.27+0.0% | 1.27-99.6% | 294.12+0.0% | 294.12+737.0% | 35.14+0.0% | 35.14+19422.2% | 0.18-99.7% | 52.48 |
| Total Income | 1.27+0.0% | 1.27-99.6% | 294.12+0.0% | 294.12+737.0% | 35.14+0.0% | 35.14+19422.2% | 0.18-99.7% | 52.48 |
| EXPENSES | ||||||||
| Expenditure | 115.06+0.0% | 115.06-6.9% | 123.64+0.0% | 123.64-20.7% | 155.96+0.0% | 155.96+44.9% | 107.67-5.5% | 113.90 |
| Tax | — | 0.00 | 0.00 | — | — | — | 0.00-100.0% | 0.03 |
| PROFIT | ||||||||
| Net Profit | -99.35+0.0% | -99.35-154.2% | 183.38+0.0% | 183.38+267.0% | -109.78+0.0% | -109.78-6.3% | -103.30-75.7% | -58.79 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00%-157.96pp | 57.96% | 57.96%+157.96pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00%-162.35pp | 62.35% | 62.35%+162.35pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.72+0.0% | -0.72-153.7% | 1.34+0.0% | 1.34+267.5% | -0.80+0.0% | -0.80+4.8% | -0.84-75.0% | -0.48 |
Corporate Events
Board MeetingDNLI
20263Jun
Board Meeting
Annual meeting of stockholders to vote on the election of th…
SEC Filing ↗